Next Generation News and Research

RSS

HIVMA and AAHIVM urge lawmakers to make medical care the top priority for Ryan White Programs

The nation’s frontline HIV medical providers are calling for an end to waiting lists for essential anti-AIDS drugs that patients need in order to live.

8 Mar 2005

VIRxSYS novel HIV gene therapy yields exciting results

VIRxSYS Corporation reports unexpected and unprecedented findings in its ongoing Phase I clinical trial of its VRX496 therapy in patients with HIV.

28 Feb 2005

Deaths from mesothelioma will peak within ten years in the UK

Deaths from mesothelioma, an asbestos-related lung cancer, will peak within ten years in the UK and then fall to a much lower level, according to new figures published in this week's British Journal of Cancer.

17 Feb 2005

Achieva 3T MR Scanner launched officially launched

The first 'next generation' MRI (magnetic resonance imaging) body scanner in the world will be officially launched at Hope Hospital later this week (Friday 18th February).

15 Feb 2005

Survey finds online health information poised to become important resource for seniors, but not there yet

As the Internet becomes an increasingly important resource for informing decisions about health and health care options, a new national survey of older Americans by the Kaiser Family Foundation finds that less than a third (31%) of seniors (age 65 and older) have ever gone online, but that more than two-thirds (70%) of the next generation of seniors (50-64 year-olds) have done so.

12 Jan 2005

Abraxane, first in a new class of albumin-bound nanotechnology for the treatment of metastatic breast cancer

Abraxane (paclitaxel protein-bound particles for injectable suspension), a next generation taxane, and the first in a new class of albumin-bound nanotechnology, was approved for the treatment of metastatic breast cancer.

9 Jan 2005

FDA approves Abraxane for metastatic breast cancer

American Pharmaceutical Partners, Inc. and American Bioscience, Inc. (ABI) announced that the U.S. Food and Drug Administration (FDA) has approved Abraxane for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) in metastatic breast cancer.

9 Jan 2005

Advanced wound care products to power expansion of European wound care market

The USD 1,111.1 million European wound care market is projected to gradually transition from traditional to advanced wound dressings. While traditional dressings currently dominate the total market, rising awareness of the clinical benefits provided by advanced wound dressings are set to widen their uptake.

7 Dec 2004

Next-generation therapeutics with the potential to successfully treat Lou Gehrig's disease

The hopes of many that ALS (commonly referred to as Lou Gehrig's disease) will one day be a disease of the past, studied in medical textbooks, conquered by the dedication of those who have worked tirelessly to eradicate it might be realized in our lifetime.

6 Dec 2004

Scientists have given blind nerve cells the ability to detect light

Scientists at the University of California, Berkeley, have given "blind" nerve cells the ability to detect light, paving the way for an innovative therapy that could restore sight to those who have lost it through disease.

24 Nov 2004

Female condoms should be promoted as an effective solution to prevent the spread of HIV/AIDS

While scientists work to find the 'perfect' solution to preventing the spread of HIV/AIDS, a reasonable option--the female condom--is not being promoted, especially in African and southeast Asian countries where the deadly virus is most prevalent, according to a new study.

24 Nov 2004

Breakthrough HIV research wins prestigious industry award

Research that could lead to a breakthrough in the treatment of HIV has scooped a University of Manchester scientist a prestigious industry award.

From The University of Manchester 23 Nov 2004

Americans encouraged to stay in touch with their family history for health reasons

The United States Department of Health and Human Services is encouraging Americans to learn about their families' health histories as a way of promoting personal health and preventing disease.

9 Nov 2004

Merck licenses new and improved methods for developing antibiotics from San Diego State University

Two new and improved methods of developing antibiotics discovered at San Diego State University have been licensed to Merck Pharmaceuticals for $300,000, the largest technology transfer agreement so far for SDSU.

9 Nov 2004

Scientists enticed back to Australia to tackle major health challenges

CSIRO and the Queensland Government are attracting leading overseas-based Australian scientists to return to work on major health challenges at the e-health Research Centre in Brisbane.

8 Nov 2004

Patent litigation the most commonly used generic defense strategy among pharmaceutical companies

Patent litigation remains the most commonly used generic defense strategy among pharmaceutical companies. 71% of drug companies have used legal battles to defend their patents in the past three years, according to research from pharmaceutical business intelligence firm Cutting Edge Information.

4 Nov 2004

Next Generation News and Research

HIVMA and AAHIVM urge lawmakers to make medical care the top priority for Ryan White Programs

VIRxSYS novel HIV gene therapy yields exciting results

Deaths from mesothelioma will peak within ten years in the UK

Achieva 3T MR Scanner launched officially launched

Survey finds online health information poised to become important resource for seniors, but not there yet

Abraxane, first in a new class of albumin-bound nanotechnology for the treatment of metastatic breast cancer

FDA approves Abraxane for metastatic breast cancer

Advanced wound care products to power expansion of European wound care market

Next-generation therapeutics with the potential to successfully treat Lou Gehrig's disease

Scientists have given blind nerve cells the ability to detect light

Female condoms should be promoted as an effective solution to prevent the spread of HIV/AIDS

Breakthrough HIV research wins prestigious industry award

Americans encouraged to stay in touch with their family history for health reasons

Merck licenses new and improved methods for developing antibiotics from San Diego State University

Scientists enticed back to Australia to tackle major health challenges

Patent litigation the most commonly used generic defense strategy among pharmaceutical companies

Research speeds development of brain-controlled devices that may allow amputees and paraplegics to use their limbs

New $22 million dollar scholarship program to recruit the next generation of public health leaders

Findings could lead to improvements in the next generation of implantable cardioverter defibrillators

MedImmune bumps up production of FluMist vaccine

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News